- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Advocates are pleased with CMS’ recent projection that average monthly premiums for Medicare Advantage (MA) and Part D prescription drug plans will decline in 2026, but they’re urging policymakers to take additional steps to shore up program stability and avoid potential hikes in out-of-pocket costs or cuts to supplemental benefits.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us